Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » The Scan » Just for US?

Just for US?

Mar 16, 2020

The Trump Administration may have offered a German biopharmaceutical firm working on a vaccine against SARS-CoV-2, the virus behind the COVID-19 pandemic, a large sum of money for the exclusive right to the vaccine, the Guardian reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

What's Popular?

In Business News

  1. WuXi Diagnostics Closes $150M Series B Financing Round

  2. NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

  3. Myriad Genetics Quarterly Revenues Decline 21 Percent

  4. BioMérieux Reports 21 Percent Revenue Growth in Q4

  5. Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.